Mallinckrodt-Endo Merger: Creating a Specialty Pharma Powerhouse in Post-Bankruptcy Renaissance

Posted by | Mar 14, 2025 |

Two Pharmaceutical Companies Emerge from Bankruptcy to Form $6.7 Billion Combined Entity with...

Read More